Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#1900 Well-Differentiated G1/G2 Pancreatic NETs Can Evolve Towards G3 Tumors
Introduction: Well-differentiated G1/G2 pancreatic NET (pNET) may evolve towards well-differentiated G3 pNET or carcinoma (pNEC)
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Olivia H
Authors: Hentic O, Cros J, Rebours V, Zappa M, Muller N,
Keywords: dedifferentiation, new biopsy,
Introduction: The 18F-FDG uptake assessed by PET/CT is correlated to prognosis in most tumors.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author:
Authors: Bucau M, Laurent-Bellue A, Cros J, Hentic O, Rebours V,
Keywords: Neuroendocrine tumors, PET-scan, 18-FDG, Ki67, VHL, metabolism,
Introduction: Patients with PNET might benefit from new therapeutic approaches acting on the mTOR signaling pathway. Culture of precision-cut slices could allow testing these molecules in human tumors, allowing personalized treatments.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author:
Authors: Bucau M, Cros J, Rebours V, Albuquerque M, Paradis V,
Keywords: pancreas, targeted therapies, tissue culture, neuroendocrine tumors,
Introduction: Ex vivo culture models of tissue slices are suitable to test the effect of antitumor agents in human tumors. The orexins are neuropeptides binding to G protein-coupled receptors (OX1-R and OX2-R), exerting a pro-apoptotic effect in human colon and pancreatic cancer cell lines.
Conference: 9th Annual ENETSConcerence (2012)
Presenting Author:
Authors: Palazzo M, Rebours V, Voisin T, Albuquerque M, Paradis V,
Keywords: digestive NET, orexins, apoptosis, ex vivo model,
Introduction: Temozolomide (TEM) is an oral drug with encouraging results in pancreatic NETs (PNETs). MGMT tumor deficiency seems to be correlated with higher treatment efficacy.
Conference: 9th Annual ENETSConcerence (2012)
Presenting Author:
Authors: Hentic O, Cros J, Rebours V, Zappa M, Maire F,
Keywords: neuroendocrine tumor, treatment, temozolomide, MGMT,